Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thirumurthy Madhavan

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Biomolecular Structure & Dynamics|August 7, 2018
Toward a better understanding of the interaction between somatostatin receptor 2 and its ligands: a structural characterization study using molecular dynamics and conceptual density functional theorySanthosh Kumar Nagarajan, Sathya Babu, Honglae Sohn, et al.
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
XGBPred-ACSM: A Hybrid Descriptor-Driven XGBoost Framework for Anticancer Small Molecule PredictionPriya Dharshini Balaji, Subathra Selvam, Anuradha Thiagarajan, et al.
Computational Biology and Chemistry|November 21, 2017
3D-QSAR studies on indole and 7-azoindole derivatives as ROCK-2 inhibitors: An integrative computational approachSanthosh Kumar Nagarajan, Sathya Babu, Honglae Sohn, et al.
Toxics|August 25, 2023
Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Ketoprofen through Inhibition of RNA Binding Protein PUM1Ravi Gor, Ali Gharib, Priya Dharshini Balaji, et al.
Discover Oncology|June 13, 2024
Repurposing FDA-approved compounds to target JAK2 for colon cancer treatmentBavya Chandrasekhar, Ravi Gor, Satish Ramalingam, et al.
In Silico Pharmacology|August 26, 2024
In-silico binding affinity of a phage display library screened novel peptide against various FABPsHarshita Shand, Soumendu Patra, Bavya Chandrasekhar, et al.
Chemical Biology & Drug Design|July 5, 2011
3D-QSAR studies of JNK1 inhibitors utilizing various alignment methodsThirumurthy Madhavan, Jae Yoon Chung, Gugan Kothandan, et al.
European Journal of Medicinal Chemistry|July 5, 2011
Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domainGugan Kothandan, Changdev G Gadhe, Thirumurthy Madhavan, et al.
Frontiers in Pharmacology|May 9, 2022
Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design ApproachesSathya Babu, Santhosh Kumar Nagarajan, Sruthy Sathish, et al.
Journal of Molecular Structure|August 25, 2020
Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike proteinSeema A Kulkarni, Santhosh Kumar Nagarajan, Veena Ramesh, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Biomolecular Structure & Dynamics|August 7, 2018
Toward a better understanding of the interaction between somatostatin receptor 2 and its ligands: a structural characterization study using molecular dynamics and conceptual density functional theorySanthosh Kumar Nagarajan, Sathya Babu, Honglae Sohn, et al.
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
XGBPred-ACSM: A Hybrid Descriptor-Driven XGBoost Framework for Anticancer Small Molecule PredictionPriya Dharshini Balaji, Subathra Selvam, Anuradha Thiagarajan, et al.
Computational Biology and Chemistry|November 21, 2017
3D-QSAR studies on indole and 7-azoindole derivatives as ROCK-2 inhibitors: An integrative computational approachSanthosh Kumar Nagarajan, Sathya Babu, Honglae Sohn, et al.
Toxics|August 25, 2023
Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Ketoprofen through Inhibition of RNA Binding Protein PUM1Ravi Gor, Ali Gharib, Priya Dharshini Balaji, et al.
Discover Oncology|June 13, 2024
Repurposing FDA-approved compounds to target JAK2 for colon cancer treatmentBavya Chandrasekhar, Ravi Gor, Satish Ramalingam, et al.
In Silico Pharmacology|August 26, 2024
In-silico binding affinity of a phage display library screened novel peptide against various FABPsHarshita Shand, Soumendu Patra, Bavya Chandrasekhar, et al.
Chemical Biology & Drug Design|July 5, 2011
3D-QSAR studies of JNK1 inhibitors utilizing various alignment methodsThirumurthy Madhavan, Jae Yoon Chung, Gugan Kothandan, et al.
European Journal of Medicinal Chemistry|July 5, 2011
Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domainGugan Kothandan, Changdev G Gadhe, Thirumurthy Madhavan, et al.
Frontiers in Pharmacology|May 9, 2022
Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design ApproachesSathya Babu, Santhosh Kumar Nagarajan, Sruthy Sathish, et al.
Journal of Molecular Structure|August 25, 2020
Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike proteinSeema A Kulkarni, Santhosh Kumar Nagarajan, Veena Ramesh, et al.
Pageof 5